170 related articles for article (PubMed ID: 27579330)
1. The Relationship of Cytokines IL-13 and IL-17 with Autoantibodies Profile in Early Rheumatoid Arthritis.
Siloşi I; Boldeanu MV; Cojocaru M; Biciuşcă V; Pădureanu V; Bogdan M; Badea RG; Avramescu C; Petrescu IO; Petrescu F; Siloşi CA
J Immunol Res; 2016; 2016():3109135. PubMed ID: 27579330
[TBL] [Abstract][Full Text] [Related]
2. Serum Biomarkers for Discrimination between Hepatitis C-Related Arthropathy and Early Rheumatoid Arthritis.
Siloşi I; Boldeanu L; Biciuşcă V; Bogdan M; Avramescu C; Taisescu C; Padureanu V; Boldeanu MV; Dricu A; Siloşi CA
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28629188
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF
Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185
[TBL] [Abstract][Full Text] [Related]
4. Elevated autoantibodies against interleukin-17F correlate with disease activity in patients with early rheumatoid arthritis.
Yang L; Bai L; Wei F; Liu Y; Sun L; Wang W; Liu X; Wang Y
Int J Rheum Dis; 2016 Jul; 19(7):644-50. PubMed ID: 26087054
[TBL] [Abstract][Full Text] [Related]
5. Cytokines (IL-15, IL-21, and IFN-γ) in rheumatoid arthritis: association with positivity to autoantibodies (RF, anti-CCP, anti-MCV, and anti-PADI4) and clinical activity.
Reyes-Pérez IV; Sánchez-Hernández PE; Muñoz-Valle JF; Martínez-Bonilla GE; García-Iglesias T; González-Díaz V; García-Arellano S; Cerpa-Cruz S; Polanco-Cruz J; Ramírez-Dueñas MG
Clin Rheumatol; 2019 Nov; 38(11):3061-3071. PubMed ID: 31312989
[TBL] [Abstract][Full Text] [Related]
6. Relation of IL-6, IL-13 and IL-15 gene polymorphisms to the rheumatoid factors, anti-CCP and other measures of rheumatoid arthritis activity.
Pavkova Goldbergova M; Nemec P; Lipkova J; Jarkovsky J; Gatterova J; Ambrozkova D; Vasku A; Soucek M; Pavek N
Int J Immunogenet; 2014 Feb; 41(1):34-40. PubMed ID: 23773307
[TBL] [Abstract][Full Text] [Related]
7. Immunodiagnostic significance of anti-RA33 autoantibodies in Saudi patients with rheumatoid arthritis.
Al-Mughales JA
J Immunol Res; 2015; 2015():604305. PubMed ID: 25883991
[TBL] [Abstract][Full Text] [Related]
8. A distinct multicytokine profile is associated with anti-cyclical citrullinated peptide antibodies in patients with early untreated inflammatory arthritis.
Hitchon CA; Alex P; Erdile LB; Frank MB; Dozmorov I; Tang Y; Wong K; Centola M; El-Gabalawy HS
J Rheumatol; 2004 Dec; 31(12):2336-46. PubMed ID: 15570632
[TBL] [Abstract][Full Text] [Related]
9. IL-22+ CD4+ T cells in patients with rheumatoid arthritis.
Zhao L; Jiang Z; Jiang Y; Ma N; Zhang Y; Feng L; Wang K
Int J Rheum Dis; 2013 Oct; 16(5):518-26. PubMed ID: 24164838
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of anti-modified citrullinated vimentin in rheumatoid arthritis.
Maraina CH; Nurdayana AK; Rusni D; Azwany Y
Int J Rheum Dis; 2010 Oct; 13(4):335-9. PubMed ID: 21199468
[TBL] [Abstract][Full Text] [Related]
11. Elevated serum and synovial fluid TNF-like ligand 1A (TL1A) is associated with autoantibody production in patients with rheumatoid arthritis.
Sun X; Zhao J; Liu R; Jia R; Sun L; Li X; Li Z
Scand J Rheumatol; 2013; 42(2):97-101. PubMed ID: 23311967
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
[TBL] [Abstract][Full Text] [Related]
13. Anti-CCP and RF IgM: predictors of impaired endothelial function in rheumatoid arthritis patients.
Hjeltnes G; Hollan I; Førre Ø; Wiik A; Mikkelsen K; Agewall S
Scand J Rheumatol; 2011 Nov; 40(6):422-7. PubMed ID: 22150462
[TBL] [Abstract][Full Text] [Related]
14. Association of serum lipids with autoantibodies and inflammatory markers in rheumatoid arthritis patients.
Gan L; He Y; Liu L; Ou Q; Lin J
Clin Chim Acta; 2018 Nov; 486():282-290. PubMed ID: 30130534
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory markers in patients with rheumatoid arthritis.
Shrivastava AK; Singh HV; Raizada A; Singh SK; Pandey A; Singh N; Yadav DS; Sharma H
Allergol Immunopathol (Madr); 2015; 43(1):81-7. PubMed ID: 24656623
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies against interleukin-21 correlate with disease activity in patients with rheumatoid arthritis.
Xing R; Sun L; Wu D; Jin Y; Li C; Liu X; Zhao J
Clin Rheumatol; 2018 Jan; 37(1):75-80. PubMed ID: 29019047
[TBL] [Abstract][Full Text] [Related]
17. Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset.
Berglin E; Johansson T; Sundin U; Jidell E; Wadell G; Hallmans G; Rantapää-Dahlqvist S
Ann Rheum Dis; 2006 Apr; 65(4):453-8. PubMed ID: 16176994
[TBL] [Abstract][Full Text] [Related]
18. Anti-cyclic citrullinated peptide antibody and rheumatoid factor isotypes in Iranian patients with rheumatoid arthritis: evaluation of clinical value and association with disease activity.
Shakiba Y; Koopah S; Jamshidi AR; Amirzargar AA; Massoud A; Kiani A; Nicknam MH; Nazari B; Nikbin B
Iran J Allergy Asthma Immunol; 2014 Jun; 13(3):147-56. PubMed ID: 24659118
[TBL] [Abstract][Full Text] [Related]
19. IL-17 patterns in synovium, serum and synovial fluid from treatment-naïve, early rheumatoid arthritis patients.
Roşu A; Mărgăritescu C; Stepan A; Muşetescu A; Ene M
Rom J Morphol Embryol; 2012; 53(1):73-80. PubMed ID: 22395503
[TBL] [Abstract][Full Text] [Related]
20. Identification of serum interleukin-13 and interleukin-13 receptor subunit expressions: Rheumatoid arthritis-associated interstitial lung disease.
Hussein MS; El-Barbary AM; Nada DW; Gaber RA; Elkolaly RM; Aboelhawa MA
Int J Rheum Dis; 2021 Apr; 24(4):591-598. PubMed ID: 33638296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
